AltPep Corporation
AltPep Corporation, based in Seattle, WA, is a pioneering biotechnology company focused on transforming the diagnosis and treatment of amyloid diseases, including Alzheimer's and Parkinson's. By targeting early molecular triggers, AltPep aims to enable earlier interventions that could significantly change disease progression for over a billion people worldwide.
The company's innovative platform relies on a growing library of custom-designed synthetic peptides that selectively bind to toxic soluble oligomers, facilitating both detection and neutralization throughout disease progression. With promising developments in diagnostics and therapeutics, AltPep is committed to making breakthrough advancements in the early detection and modification of amyloid diseases.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.


